Lara Bull–Otterson

Centers for Disease Control and Prevention

Also affiliated with National Center for Emerging and Zoonotic Infectious Diseases, Center for Surveillance, Epidemiology, and Laboratory Services

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010–2017”.

Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010–2017

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa017

N/A

0.593DataRank · unranked

51 citations

Ya-Lin A. Huang, Weiming Zhu, Hope King, Brian R. Edlin, Karen W. Hoover +1 more

Relative Effectiveness of Coronavirus Disease 2019 Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Period—United States, 1 January 2022 to 31 March 2022

Clinical Infectious Diseases(2023)10.1093/cid/ciad063

N/A

0.385DataRank · unranked

12 citations

Ryan E. Wiegand, Adewole C Oyalowo, Lara Bull–Otterson, Heartley Egwuogu, Trevor Thompson +12 more